噬菌体和机器人辅助的近乎连续进化的实用指南
January 12th, 2024
2.4K views
噬菌体和机器人辅助近连续进化 （PRANCE） 是一种快速、稳健的蛋白质进化技术。机器人技术允许实验的并行化、实时监控和反馈控制。
我们正试图使神秘的进化过程具有足够的可预测性，可以用于工程。PRANCE使我们能够通过并行化将演化带入实验室时间尺度，以更好地理解它。实验室自动化正在将更通用的软件工程（包括人工智能）的概念引入到控制代码的开发中。
人们还将机械臂和多向输送系统集成到液体处理平台中。总体而言，自动化包括更先进的仪器和工作流程。反馈控制通过防止常见的故障模式（如灭绝）来提高持续进化的成功率。
这在分子具有不同起始活性的多重进化过程中至关重要，动态进化的严格性对于所需的结果至关重要。新的科学问题包括探索不同条件如何影响进化，以及研究对噬菌体繁殖和进化电路效率的影响。通过这些改进的蛋白质工程工具，我们希望设计出更复杂的蛋白质，这些蛋白质对其环境敏感且功能动态。
概述
噬菌体和机器人辅助近连续进化（PRANCE）是一种专为快速和稳健的蛋白质进化设计的新技术。通过利用机器人技术，该方法允许实验的并行化、实时监控和反馈控制，从而增强实验室环境中进化过程的可预测性。
关键研究组成部分
科学领域
- 蛋白质工程
- 进化生物学
- 实验室自动化
背景
- PRANCE将软件工程和人工智能的概念整合到实验室工作流程中。
- 自动化包括先进的仪器设备，如机械臂和输送系统。
- 反馈控制对于防止多重进化过程中的灭绝至关重要。
- 动态进化严格性对于实现预期结果至关重要。
研究目的
- 使进化过程对工程应用具有可预测性。
- 探索不同条件如何影响进化和噬菌体繁殖。
- 工程对环境变化敏感的复杂蛋白质。
使用的方法
- 用于实验并行化的机器人技术。
- 对进化过程的实时监控。
- 用于增强连续进化的反馈控制机制。
- 先进液体处理平台的集成。
主要结果
- 通过反馈控制提高了连续进化的成功率。
- 洞察不同条件对进化效率的影响。
- 开发了具有动态功能和环境敏感性的蛋白质。
- 增强了对多重进化挑战的理解。
结论
- PRANCE代表了蛋白质工程技术的重大进步。
- 自动化和反馈控制是成功进化实验的关键。
- 未来的研究将侧重于优化蛋白质进化的条件。
常见问题
什么是PRANCE？
PRANCE代表噬菌体和机器人辅助近连续进化，是一种用于快速蛋白质进化的技术。
机器人如何增强PRANCE方法？
机器人技术允许实验的并行化和实时监控，提高了蛋白质进化的效率。
反馈控制在PRANCE中扮演什么角色？
反馈控制有助于防止多重进化过程中的灭绝，确保成功的结果。
PRANCE的主要应用是什么？
PRANCE用于工程能够适应其环境的复杂蛋白质。
PRANCE解决了哪些科学问题？
它探索了不同条件对进化和噬菌体繁殖效率的影响。
PRANCE为蛋白质工程带来了哪些进步？
它结合了自动化和先进的仪器设备，以增强蛋白质进化的可预测性和成功率。
Executive Industry Relevance
Phage- and Robotics-assisted Near-continuous Evolution (PRANCE) enables rapid, parallelized protein engineering with real-time feedback, addressing the unpredictability of evolutionary processes in R&D. By integrating robotics and feedback control, PRANCE supports scalable, multiplexed evolution experiments, reducing failure modes and enhancing experimental reliability. This capability is strategically positioned to accelerate early discovery and de-risk protein engineering portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables systematic interrogation of protein function and evolutionary pathways under controlled conditions.
- Supports biological de-risking by preventing extinction events during multiplexed evolution.
- Facilitates predictive confidence in engineered protein candidates through real-time feedback control.
Screening & Assay Development
- Prepares validated, feedback-controlled evolution systems for downstream screening workflows.
- Standardizes assay conditions across hundreds of parallel experiments, improving reproducibility.
- Enables scalable, high-throughput evaluation of protein variants for functional optimization.
Translational & Preclinical Research
- Aligns engineered protein outputs with dynamic, environment-sensitive functions relevant to disease models.
- Supports continuity from discovery through preclinical validation by enabling robust, multiplexed evolution.
- Provides mechanistic insights into phage propagation and evolution circuit efficiency for translational applications.
Pipeline & Workflow Integration
PRANCE is positioned at the intersection of early discovery, lead identification, and preclinical research, enabling continuous evolution and rapid iteration of protein candidates.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling controlled, parallel evolution experiments.
- Screening: Delivers reproducible, quantitative outputs for reliable comparison of protein variants.
- Analytics: Provides real-time monitoring and feedback data to inform experimental adjustments and decision-making.
- Translational Research: Bridges discovery and preclinical stages by generating proteins with dynamic, disease-relevant properties.
- Enterprise Reuse: Establishes a scalable, reusable platform for ongoing protein engineering initiatives.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in protein evolution.
- Operational Value: Delivers standardized, reproducible, and scalable evolution workflows.
- Strategic Value: Enables informed go/no-go decisions and capital-efficient portfolio advancement.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of engineered protein candidates.
Implementation Considerations
- Requires expertise in robotics, liquid handling, and feedback control systems.
- Demands integration of plate readers, pumps, heaters, and compatible software infrastructure.
- Necessitates cross-team standardization for multiplexed experiment setup and data analysis.
- Adaptation across different protein targets and evolution circuits may require protocol optimization.
- Practical limitations include initial equipment setup complexity and validation of system readiness.
Biopharma FAQs
Why does null hypothesis testing matter for PRANCE-based target validation?
Null hypothesis testing in PRANCE experiments enables objective assessment of whether observed protein evolution outcomes are statistically significant, supporting robust target validation. This reduces the risk of false positives in early discovery. Reliable statistical frameworks are essential for portfolio decision-making.
How does independent variable isolation fit PRANCE's multiplexed evolution pipeline?
Isolating independent variables in PRANCE allows teams to systematically evaluate the impact of specific conditions on protein evolution across parallel experiments. This supports mechanistic de-risking and informs optimization strategies for future campaigns.
What do quantitative dependent variable measurements enable in PRANCE workflows?
Quantitative measurements, such as real-time readouts from plate readers, enable precise monitoring of evolutionary progress and feedback control. These outputs support reproducibility and facilitate data-driven optimization of protein engineering experiments.
Why are replication requirements critical for cross-functional PRANCE collaboration?
Replication across hundreds of parallel PRANCE experiments ensures that findings are robust and transferable between teams. This standardization is vital for cross-functional collaboration and enterprise-scale protein engineering efforts.
What statistical analysis capabilities are required before PRANCE implementation?
Robust statistical analysis tools are needed to interpret multiplexed evolution data, assess significance, and guide feedback control decisions. These capabilities are essential for ensuring reliable, actionable outputs in biopharma R&D pipelines.
